There are 3161 resources available
Presentation of case/condition
Presenter: Paolo Bironzo
Session: MRD or molecular tumour board case report
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Christos Sotiriou
Session: Evolving biomarkers in metastatic disease: Liquid, solid or both?
Resources:
Slides
Webcast
Pragmatic trials: General introduction
Presenter: Denis Lacombe
Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?
Resources:
Slides
Webcast
LBA1 - A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3
Presenter: Silke Gillessen
Session: Presidential Symposium I: Practice-changing trials
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA1
Presenter: Karim Fizazi
Session: Presidential Symposium I: Practice-changing trials
Resources:
Slides
Webcast
Navigating the molecular tumour board and genomic reports
Presenter: Joaquin Mateo
Session: MRD or molecular tumour board case report
Resources:
Slides
Webcast
Liquid biopsy: Promises and challenges
Presenter: Michail Ignatiadis
Session: Evolving biomarkers in metastatic disease: Liquid, solid or both?
Resources:
Slides
Webcast
The Cancer Medicine Forum of the EMA
Presenter: Francesco Pignatti
Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?
Resources:
Slides
Webcast
Tissue biopsy: Capturing tumour microenvironment and beyond
Presenter: Frederique Penault-Llorca
Session: Evolving biomarkers in metastatic disease: Liquid, solid or both?
Resources:
Slides
Webcast
Designing, running and funding deescalation clinical trials
Presenter: Daniel Goldstein
Session: Can pragmatic clinical trials and optimisation of treatments support development, access and value?
Resources:
Slides
Webcast